Amoy Diagnostics (AmoyDx, 艾德生物) is a company that provides molecular diagnostic products and services for oncology precision medicine. It offers test kits, including NGS (next-generation sequencing), PCR (polymerase chain reaction), and FISH (fluorescence in situ hybridization) assays, as well as DNA and RNA extraction kits. The company serves healthcare providers, academic institutions, and pharmaceutical businesses.
Type | Public | |
Founded | 2008 | |
HQ | Xiamen, CN | Map |
Website | amoydiagnostics.com |
CNY | |
---|---|
Revenue (Q1, 2022) | 205.4m |
Gross profit (Q1, 2022) | 170.7m |
Gross profit margin (Q1, 2022), % | 83.1% |
Net income (Q1, 2022) | 53.3m |
EBITDA (Q1, 2022) | 55.7m |
EBIT (Q1, 2022) | 58.3m |
Market capitalization (2-Aug-2022) | 5.9b |
Closing stock price (2-Aug-2022) | 26.7 |
Cash (31-Mar-2022) | 441.8m |
EV | 5.5b |
CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Revenue | 435.5m | 573.8m | 719.9m | 903.9m |
Cost of goods sold | (39.4m) | (55.7m) | (94.9m) | (143.3m) |
Gross profit | 396.9m | 518.9m | 630.1m | 769.6m |
Gross profit Margin, % | 91% | 90% | 88% | 85% |
CNY | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 118.8m | 145.3m | 145.7m | 90.3m | 280.0m | 111.8m | 173.0m | 219.8m | 250.1m | 205.4m |
Cost of goods sold | (10.6m) | (14.4m) | (14.9m) | (11.6m) | (33.6m) | (15.8m) | (30.3m) | (31.8m) | (41.7m) | (34.7m) |
Gross profit | 108.2m | 131.3m | 130.4m | 78.7m | 248.1m | 94.4m | 142.7m | 192.2m | 204.2m | 170.7m |
Gross profit Margin, % | 91% | 90% | 90% | 87% | 89% | 84% | 82% | 87% | 82% | 83% |
CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Cash | 198.2m | 498.4m | 361.6m | 402.9m |
Accounts Receivable | 188.9m | 233.1m | 316.5m | 428.8m |
Prepaid Expenses | 1.1m | 14.2m | 1.7m | 9.1m |
Inventories | 14.1m | 17.2m | 21.4m | 32.3m |
CNY | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Cash | 241.0m | 252.9m | 262.0m | 425.7m | 362.4m | 442.8m | 376.2m | 392.1m | 346.6m | 441.8m |
Accounts Receivable | 198.5m | 213.3m | 220.4m | 207.0m | 265.0m | 272.1m | 308.5m | 353.7m | 403.9m | 447.1m |
Prepaid Expenses | 869.0k | 4.0m | 3.3m | 12.7m | 2.0m | 3.1m | 2.8m | 6.6m | 6.8m | 1.8m |
Inventories | 17.4m | 17.3m | 18.2m | 27.1m | 43.2m | 36.4m | 26.2m | 36.5m | 35.7m | 30.4m |
CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Net Income | 126.7m | 135.5m | 180.3m | 239.0m |
Depreciation and Amortization | 19.7m | 24.2m | 27.3m | 36.4m |
Inventories | (4.4m) | (3.1m) | (4.3m) | (10.8m) |
Accounts Payable | 7.0m | 54.1m | 78.0m | 19.2m |
CNY | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 78.2m | 80.8m | 80.8m | 111.3m | ||||||
Depreciation and Amortization | 11.8m | 13.1m | 13.1m | 16.8m | ||||||
Inventories | (3.3m) | (25.9m) | (25.9m) | (13.3m) | ||||||
Accounts Payable | 23.6m | 47.4m | 47.4m | 15.5m |
CNY | FY, 2018 |
---|---|
Revenue/Employee | 805.0k |
Financial Leverage | 1.1 x |
Company Name | Date | Deal Size |
---|---|---|
Shanghai Shawei Biotechnology Co., Ltd. |
Amoy Diagnostics revenue breakdown by business segment: 76.2% from REAGENT INCOME, 16.9% from TESTING SERVICE REVENUE, 5.9% from DRUG CLINICAL RESEARCH SERVICE and 1.0% from Other
Amoy Diagnostics revenue breakdown by geographic segment: 88.5% from CHINA (PEOPLES REPUBLIC) and 11.5% from REST OF WORLD
Amoy Diagnostics has 335 Twitter Followers. The number of followers has increased 0.1% month over month and increased 1.8% quarter over quarter
When was Amoy Diagnostics founded?
Amoy Diagnostics was founded in 2008.
Who are Amoy Diagnostics key executives?
Amoy Diagnostics's key executives are Li-mou Zheng.
How many employees does Amoy Diagnostics have?
Amoy Diagnostics has 654 employees.
What is Amoy Diagnostics revenue?
Latest Amoy Diagnostics annual revenue is ¥903.9 m.
What is Amoy Diagnostics revenue per employee?
Latest Amoy Diagnostics revenue per employee is ¥1.4 m.
Who are Amoy Diagnostics competitors?
Competitors of Amoy Diagnostics include MGI, ZAI Lab and Thermo Fisher Scientific.
Where is Amoy Diagnostics headquarters?
Amoy Diagnostics headquarters is located at 39 Dingshan Road, Haicang District, Xiamen.
Where are Amoy Diagnostics offices?
Amoy Diagnostics has an office in Xiamen.
How many offices does Amoy Diagnostics have?
Amoy Diagnostics has 1 office.
Receive alerts for 300+ data fields across thousands of companies